Mednutriflex E (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

Mednutriflex E is used in parenteral nutrition to provide a balanced amino acid profile for patients with increased protein needs.

• Critical illness: supports protein synthesis and nitrogen balance in catabolic or critically ill patients.
• Post‑operative care: aids recovery by supplying essential amino acids after major surgery.
• Severe burns: helps meet heightened metabolic demands and tissue repair requirements.
• Long‑term parenteral nutrition: maintains nutritional status in patients dependent on intravenous feeding.

• Mednutriflex E delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids are taken up by cells and serve as substrates for ribosomal protein synthesis, replenish intracellular nitrogen pools, and support gluconeogenesis and other metabolic pathways. By restoring amino acid availability, the solution helps maintain lean body mass and facilitates tissue repair during intravenous nutrition.

Adverse reactions to Mednutriflex E are generally related to the infusion process and the amino acid composition.

Common Side Effects

• Infusion site erythema: mild redness or irritation at the catheter entry point.
• Nausea: transient feeling of queasiness during or shortly after infusion.
• Hyperglycemia: elevated blood glucose levels, especially in diabetic patients.
• Electrolyte imbalance: mild shifts in potassium or sodium concentrations.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Metabolic acidosis: significant drop in blood pH due to excess amino acid metabolism.
• Hyperammonemia: elevated ammonia levels that may affect neurological function.
• Renal dysfunction: impaired kidney function in patients with pre‑existing renal disease.

When using Mednutriflex E, clinicians should observe several precautionary measures to ensure patient safety.

• Renal function assessment: evaluate kidney performance before and during therapy.
• Electrolyte monitoring: regularly check serum potassium, sodium, and calcium levels.
• Blood glucose control: monitor glucose in diabetic or hyperglycaemic patients.
• Hepatic impairment: adjust dosage in patients with severe liver disease.
• Hypersensitivity screening: discontinue if signs of allergic reaction appear.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mednutriflex E may interact with other medications that affect electrolyte balance, nitrogen load, or metabolic pathways.

Major Interactions (Avoid)

• High‑dose potassium chloride: risk of hyperkalemia when combined with amino acid infusion.
• Concurrent amino acid solutions: may cause excessive nitrogen load and metabolic complications.
• Certain nephrotoxic drugs (e.g., aminoglycosides): increased risk of renal impairment.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate electrolyte disturbances; monitor serum levels.
• Insulin therapy: amino acids can affect glucose metabolism; adjust insulin dosing as needed.
• Corticosteroids: may increase protein catabolism; monitor nutritional status.